FASEB BioAdvances : Impact Factor & More
eISSN: 2573-9832pISSN: 2573-9832
Open AccessShare this on:
Key Metrics
CiteScore 
2.6
SNIP
0.77
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on FASEB BioAdvances
FASEB BioAdvances Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | EUR 2200 | GBP 1850 | USD 2400 |
| Publication Time | 10 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Federation of American Societies for Experimental Biology |
| Frequency | Monthly |
| Publication Start Year | 2019 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in FASEB BioAdvances ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in FASEB BioAdvances
Interplay of RNA m6A/m1A/m5C/m7G/\u03c8 Regulators Predicting the Prognosis of Pancreatic Cancer
- 18 May 2026
- FASEB BioAdvances
Retrotransposons in Bone and Joint Diseases
- 18 May 2026
- FASEB BioAdvances
Synaptic Inhibition in the Accessory Olfactory Bulb Regulates Pheromone Location Learning and Memory.
- 1 May 2026
- FASEB bioAdvances
Title not available
- 1 May 2026
- FASEB BioAdvances
MicroRNA 15a and 16 Regulate Proteostasis in Non-Small Cell Lung Cancer.
- 1 May 2026
- FASEB bioAdvances
Enhancing the Therapeutic Profile of Dapagliflozin: Chitosan Nanoparticle Encapsulation for Intestinal Applications.
- 1 May 2026
- FASEB bioAdvances
Interplay of RNA m6A/m1A/m5C/m7G/\u03c8 Regulators Predicting the Prognosis of Pancreatic Cancer
- 18 May 2026
- FASEB BioAdvances
Retrotransposons in Bone and Joint Diseases
- 18 May 2026
- FASEB BioAdvances
Synaptic Inhibition in the Accessory Olfactory Bulb Regulates Pheromone Location Learning and Memory.
- 1 May 2026
- FASEB bioAdvances
Title not available
- 1 May 2026
- FASEB BioAdvances
MicroRNA 15a and 16 Regulate Proteostasis in Non-Small Cell Lung Cancer.
- 1 May 2026
- FASEB bioAdvances
Enhancing the Therapeutic Profile of Dapagliflozin: Chitosan Nanoparticle Encapsulation for Intestinal Applications.
- 1 May 2026
- FASEB bioAdvances
FAQs on FASEB BioAdvances
How long has FASEB BioAdvances been actively publishing? 
What is the publishing frequency of FASEB BioAdvances?
How many articles did FASEB BioAdvances publish last year?
What is the eISSN & pISSN for FASEB BioAdvances?
What is Citescore for FASEB BioAdvances?
What is SNIP score for FASEB BioAdvances?
Who is the publisher of FASEB BioAdvances?
